Carulli et al. found a polymorphism in the IL-6 gene (-174G/C) that was more prevalent in NASH versus NAFLD patients and associated with insulin resistance [25], potentially implicating IL-6 in the pathogenesis of the disease. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.